- The share
- Press releases
- Financial calendar
- Financial reports
- Prospectus and material offerings
- Financial presentations
- Corporate governance
- Analyst Coverage
- Code of Conduct
- Contact us
- Thank you
Share warrant program fully subscribed
XVIVO Perfusion AB's share warrant program 2015/2017 is fully subscribed. A total of 215,000 warrants with the right to subscribe for new shares were issued. Each warrant has in June 2017 the right to subscribe for one new share at a price of SEK 60.92.
The annual shareholder meeting April 23, 2015 approved the warrant program of a maximum of 215,000 warrants to be offered to all employees in XVIVO Perfusion AB. Upon full exercise of the warrants, the share capital increase is SEK 5,500 corresponding to a dilution of about 1 percent of the total number of shares and votes.
Magnus Nilsson, CEO of XVIVO Perfusion: “The broad support is very encouraging and it gives all of our employees a stronger shareholder interest and an even stronger incentive to fulfill our goals.”
July 2, 2015
XVIVO Perfusion AB (publ)
For further information please contact:
Christoffer Rosenblad, CFO, +46 31 788 21 59, firstname.lastname@example.org
For further information on XVIVO Perfusion’s business, please refer to the company’s website, www.xvivoperfusion.com
The information was submitted for publication on July 2, 2015 at 8:30 a.m.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.